Somite.ai, a pioneer in foundation models for human stem cells, has announced a strategic investment from AMD Ventures, following its $47 million Series A funding led by Khosla Ventures in May. The partnership will integrate Somite’s capsule-based data generation platform with AMD’s high-performance Instinct™ GPUs, delivering the computational power needed to accelerate training of advanced foundation models. Somite is driving a paradigm shift in cell therapy by developing large-scale foundation models that can drastically reduce the time and cost of creating novel treatments, with its proprietary capsule technology generating differentiation data at nearly one-thousandth the expense of conventional approaches. This breakthrough enables training of highly predictive models with unprecedented scale and accuracy, advancing the potential for transformative cell therapies that could impact millions of patients worldwide.
Also Read: IVIX Secures $60M Series B to Combat Financial Crime with AI
“We are on the cusp of a true breakthrough in data generation for cell-state transitions. Our capsule-based platform provides dense, causal datasets essential for training transformative foundation models. AMD is uniquely positioned to help us deliver on our promise,” said Dr. Micha Breakstone, Co-Founder and CEO of Somite.ai. Highlighting the synergy, Sagi Paz, Head of AMD Ventures, added, “Biology is experiencing a computational revolution similar to language and vision. Somite is clearly leading the way, and AMD Instinct GPUs are built for the demands of their ambitious models. We are excited to collaborate with a company converting cutting-edge compute capabilities into meaningful therapies.” The collaboration also includes exploring optimization of software tools for biological data and co-developing solutions tailored to next-generation foundation models, underscoring a joint commitment to accelerate breakthroughs at the intersection of biotechnology and high-performance computing.